Yasser Abou-Mourad

Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levels

Donna L. Forrest, Shannon Trainor, Ryan R. Brinkman et al. · Leukemia Research · 2008 · 81 citations

Life Sciences, Hematology, Oncology +11

Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens

Yasser Abou-Mourad, Benny Lau, M. J. Barnett et al. · Bone Marrow Transplantation · 2009 · 75 citations

Medicine, Hematology, Immunotherapy +3

Allogeneic SCT for relapsed composite and transformed lymphoma using related and unrelated donors: long-term results

Khaled M. A. Ramadan, Joseph M. Connors, Abdulwahab J. Al-Tourah et al. · Bone Marrow Transplantation · 2008 · 22 citations

Medicine, Immunology, Oncology +10

Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapy

Adisak Tantiworawit, Maryse Power, Michael J. Barnett et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2011 · 19 citations

Medicine, Hematology, Oncology +14